Skip to main content
logo
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
11.02
-0.24 (-2.13%)
At close: Oct 23, 2026, 4:00 PM EDT
11.50
+0.48 (4.36%)
After-hours: Oct 23, 2026, 6:42 PM EDT

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $56.50M in the quarter ending June 30, 2026, with 7.75% growth. This brings the company's total for the last twelve months to $231.24M, down -2.86% year-over-year. In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%. That makes Puma Biotechnology the 16,387th largest company in the world by revenue and 2,793rd in the United States.

Revenue (ttm)
$231.24M
Revenue Growth
-2.86%
P/S Ratio
2.44
Revenue / Employee
$1,291,866
Employees
179
Market Cap
568.85M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025228.37M-2.10M-0.91%
Dec 31, 2024230.47M-5.17M-2.19%
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018250.99M223.31M806.60%
Dec 31, 201727.69M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MiMedx Group355.17M
Phathom Pharmaceuticals239.66M
Zevra Therapeutics136.07M
Gyre Therapeutics109.82M
Crescent Biopharma11.88M
Aclaris Therapeutics8.22M
DBV Technologies5.04M
Shattuck Labs1.00M
Revenue Rankings

PBYI News

More News